Piper Sandler analyst Matthew Clark upgrades HomeStreet (NASDAQ:HMST) from Underweight to Neutral.
A Major October Catalyst Could Make This Eye Stock A Ten Bagger, Analyst Says
Chardan initiated coverage on Outlook Therapeutics Inc (NASDAQ: OTLK) with a Buy rati